REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.75% | 109.61% | 18.61% | 3.67% | 26.47% |
| Total Depreciation and Amortization | -3.60% | -5.38% | -7.20% | -9.40% | -8.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.89% | -39.43% | -54.71% | 3.51% | -26.54% |
| Change in Net Operating Assets | 286.77% | 301.20% | 26.39% | 1,074.16% | -139.86% |
| Cash from Operations | -8.45% | 160.64% | 22.41% | 17.93% | 3.86% |
| Capital Expenditure | 17.51% | -83.84% | 4.17% | 77.35% | 81.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68,083.01% | 233.09% | 17.81% | 26.16% | -99.64% |
| Cash from Investing | -52,301.49% | 239.40% | 18.54% | 30.01% | -100.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.66% | -81.82% | -89.63% | -- |
| Repurchase of Common Stock | 100.00% | 43.96% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,582.25% | 49.02% | 36.09% | -4.42% | 5.28% |
| Cash from Financing | 1,574.13% | -104.80% | 35.30% | -125.95% | -3.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.45% | -7.49% | 104.85% | 92.62% | -4,260.98% |